Research Topics

Adam T Waickman

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
    Adam T Waickman
    Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer Immunol Immunother 61:917-26. 2012

Detail Information

Publications1

  1. pmc Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
    Adam T Waickman
    Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer Immunol Immunother 61:917-26. 2012
    ..In light of these data, we believe that blockade of the A(2A) adenosine receptor is an attractive target for tumor immunotherapy that synergizes with other immunomodulatory approaches currently in clinical trials...